Pharmacological agents and impairment of fracture healing

Download Pharmacological agents and impairment of fracture healing

Preview text

Injury, Int. J. Care Injured (2008) 39, 384—394
Pharmacological agents and impairment of fracture healing: What is the evidence?
Ippokratis Pountos a, Theodora Georgouli a, Taco J. Blokhuis b, Hans Chistoph Pape c, Peter V. Giannoudis a,*
a Academic Department of Trauma & Orthopaedics, School of Medicine, University of Leeds, UK b Department of Surgery & Traumatology, University Medical Center Nijmegen, The Netherlands c Academic Department, Pittsburgh Medical School, Pittsburgh, USA
Accepted 31 October 2007

KEYWORDS Bone healing; Inhibition; Pharmacological agents

Summary Bone healing is an extremely complex process which depends on the coordinated action of several cell lineages on a cascade of biological events, and has always been a major medical concern. The use of several drugs such as corticosteroids, chemotherapeutic agents, non-steroidal anti-inflammatory drugs (NSAIDs), antibiotics, anticoagulants and drugs which reduce osteoclastic activity have been shown to affect bone healing. This review article presents our current understanding on this topic, focusing on data illustrating the effect of these drugs on fracture healing and bone regeneration. # 2007 Elsevier Ltd. All rights reserved.

Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 385 Chemotherapy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 385 Corticosteroids . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 386 Antibiotics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 387 Anticoagulants . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 388 NSAIDS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 388 Bisphosphonates . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 390 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 390 Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 390 Conflicts of interest . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 390 References. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 390

* Corresponding author at: Academic Department of Trauma & Orthopaedics, Leeds General Infirmary, Great George Street, Leeds LS1 3EX, UK. Tel.: +44 113 3922750; fax: +44 113 3923290.
E-mail address: [email protected] (P.V. Giannoudis).
0020–1383/$ — see front matter # 2007 Elsevier Ltd. All rights reserved. doi:10.1016/j.injury.2007.10.035

Pharmacological agents and impairment of fracture healing


Bone healing is one of the most complex cascades of events resulting in the repair of fractured bone without scar formation, and a final outcome that resembles the previous state of an unbroken bone.
This process involves the coordinated action of several cells types, along with signal pathways and local changes in the biochemical content. It includes a variety of biological changes, starting with disruption of blood supply, haematoma formation, local hypoxia and inflammation.27 Cytokine and growth factor release, together with pro-inflammatory stimuli, result in a high production of prostaglandins.99 This environment seems to force mesenchymal stem cells (MSCs) to migrate, accumulate and proliferate, reaching adequate numbers to support differentiation.33,98 Neovasculogenesis in association with further growth factor and prostaglandin production, promotes differentiation of MSCs towards chondrogenic or osteogenic lineages, initially forming woven bone and in continuity with the hard callus.27,38,99 Finally, this process is followed by an extended period of remodelling characterised by resorption and new bone formation resulting in restoration of mechanical strength and stability.22
The outcome of this process is regulated by a diversity of local and systemic factors with varying degrees of involvement (Table 1).7,8,11,19— 21,24,41,48,55,73,86,91,118,120,127 Local inhibitory factors include the presence of a fracture gap, disturbances of blood flow, concomitant infection and extensive soft tissue damage.7,120 The surgical technique, the type of fixation and the success of the fixation are also factors which influence the fracture healing responce.19,21,120,127 Insufficient mechanical stability has a negative effect on healing, resulting either in excessive or diminutive callus formation, leading to hypertrophic or hypotrophic non-unions.21,127 In addition, the metabolic and nutritional state of the
Table 1 Factors that affect fracture healing
 Type of the fracture 19  Fracture gap 7  Poor technique, inadequate reduction, abnormal
position 120  Type of fixation and mechanical stability of
fracture21,127  Infection and debris, dead tissue in wound 120  Extensive soft tissue damage 120  Blood supply-smoking 73  Metabolic and nutritional state of the patient11,24,48  Age and gender of the patient20,91  Early mobilisation 8  Accompanying diseases11,20,24,48  Drug administration41,55,86,118

patient, together with the age, gender, smoking and accompanying pathologies, contribute to the delay or diminution of healing.11,20,24,48,57,73,91 As far as smoking is concerned, delayed healing does not appear to be due to a direct effect of nicotine on bone cells, which was found to up-regulate their activity, but probably due to vascular responses to nicotine or due to the effect on bone cells of other components absorbed during smoking.50
Another important factor that is known to have an effect on the fracture healing process is the administration of different pharmacological agents.
The aim of this review article is to provide a brief overview of the current evidence of the inhibitory effect of various drugs on the fracture healing response.
Chemotherapeutic agents are widely used for the treatment of malignant lesions. Fracture healing and limb-salvage procedures including vascularised bone grafts, autografts and allografts are significantly affected by these drugs (Table 2).15,37,47,54,55,68,75,88,112,117 Their anti-proliferative and cytotoxic properties have a great effect on neovasculogenesis,54 proper callus formation and host bone-allograft incorporation resulting in higher non-union rates.55,59 Similarly, anti-angiogenesis agents have a detrimental effect on fracture healing and the outcome resembles atrophic non-union.54
Several animal models have illustrated the effect of chemotherapy drugs on bone healing. Studies with the use of doxorubicin, cyclophosphamide, adriamycin and methotrexate reported diminution of bone formation.15,37,112 Chemical analysis of the callus showed diminished calcium and phosphatase deposition with the use of cyclophosphamide.108 Nilsson et al. showed that the inhibitory effects of methotrexate on bone formation persisted for at least three weeks after administration.88 In an animal model of spinal fusion, a single dose of adriamycin during surgery resulted in a significant inhibitory effect on the process of fusion.117
Distraction osteogenesis could be an alternative limb-salvage procedure as it does not seem to be affected by chemotherapy agents.47,115 Alternatively, approaches with tissue-engineering with the use of MSCs could be used.73 In rats receiving chemotherapy, the application of MSCs into an experimentally induced femoral defect produced bone formation similar to the non-chemotherapy treated animals.73 Such approaches may be beneficial for treatment of bone defects in patients undergoing chemotherapy.


I. Pountos et al.

Table 2 Chemotherapeutic agents’ effect on fracture healing


Model used Drug

1983/Burchardt 15


Doxorubicin and Methotrexate

1983/Sommer-Tsilenis 112 Rats


1984/Nilsson 88




Methotrexate Doxorubicin and Methotrexate

1992/Khoo 68 2001/Hausman 54
2001/Hazan 55 2001/Subasi 115
2003/Gravel 47 2004/Li 75

Rabbits Rats
Humans Rabbits
Goats In vitro (MSCs)

na Methotrexate (osteosarcoma regimen) Doxorubicine
Arsenic trioxide, Busulphan, Cyclophasphomide, Methotrexate, Cytarabine, Etoposide, Dexamentasone, Vincristine, Pacilitaxel

 Decrease of bone formation
 Inhibition of collagen formation  Delayed mineralisation
 Inhibition of bone formation
 Diminished bone formation  The number of osteoblasts and
osteoclasts was unaffected
 Impairment of bone healing
 Result resembles atrophic non-union  Suppressed callus and woven bone
 High increase of non-union rates  This regimen had no effect on
distraction osteogenesis  No effect on distraction osteogenesis
 Variability of affection
 Paclitaxel, vincristine, etoposide and cytarabine had higher degree of affection

2004/Tortolani 117 na: not available.



 Inhibition of spinal fusion

The effect of corticosteroids on bone metabolism has been well documented. Corticosteroids induce osteoporosis, and they are the most common cause of secondary osteoporosis. Steroid administration leads to osteoblast apoptosis, osteocyte apoptosis, and inhibition of osteoblastogenesis89,123 resulting in

a decreased bone density. The inhibitory effect of
corticosteroids on fracture healing seems logical, but
not all animal studies have shown consistent results.
A number of studies have been conducted on the
effect of corticosteroids on bone healing (Table 3).6,13,31,32,58,67,78,86,106,107,111,122,124 In the
1950s, Blunt et al. first studied the effect of corticosteroids on bone healing.13 They reported that

Table 3 The effect of steroids on fracture healing

Year/study 1951/Blunt 13

Model used Rabbits

Drug Cortisone

1951/Sissons 111



1952/Key67 1964/Weiss 124 1966/Murakami 86 1972/Ehrlich31,32 1986/Sato 106 1992/Hogevold 58
2000/Waters 122

Rats Rats Guinea pigs Rats Rats Rats

Cortisone Cortisone Cortisone Prednisone Dexamethasone Methylprednisolone

2001/Sawin 107 2002/Luppen 78
2005/Aslan 6

Rabbits Rabbits

Dexamethasone Prednisolone

 Decreased callus formation
 Retardation of healing  Abnormal histological appearance
 No inhibitory effect encountered  No inhibitory effect encountered  Retardation of bone healing  Inhibition of collagens synthesis  Retardation of mineralisation  No inhibitory effect encountered
 Lower callus size and mineral content  Chronic administration resulted in weaker bone
 Inhibition of bone graft incorporation in spinal fusion  25% lower callus area and 55% inhibition of torsional
strength  No inhibitory effect encountered

Pharmacological agents and impairment of fracture healing


callus formation was decreased in rabbits receiving cortisone.13 In addition, absence of periosteal bone
and abnormal histological processes were described by Sisson and Hadfield.111 Thereafter, a number of
controversial studies were published presenting dif-
ferent results. Several rat studies failed to prove any inhibitory effect,6,58,67,124 whereas others
described a detrimental effect on bone healing.56,122,125 Waters et al., in a rabbit model of
fracture healing treated with prednisone, found
decreased callus volume, decreased mineral content and weaker repair of the fracture.122 Similarly,
in an experimental model of posterolateral lumbar
spinal arthrodesis in rabbits, dexamethasone inhib-
ited graft incorporation and had a higher rate of non-union.107 In wound healing the treatment of
rats with glucocorticoids seemed to decrease the
rate of fibroblasts and collagen accumulation, and as consequence the tensile strength.31,32
The reason for these differing results is still
unknown. Jee and co-workers stated that cortisone has a dose dependant effect on bone.63 In addition,
Duthie and Barker found that endochondral ossifica-
tion was clearly retarded in rats treated with corti-
sone but membranous ossification was not affected.30 Recent data suggest that the presence
of glucocorticoid receptors GRa at osteoblasts,
chondrocytes and osteocytes might play a role in endochondral bone formation.1 Therefore, the ani-
mal model, the duration and dosage of drugs admi-
nistered as well as the traumatic extent of the
experimentally induced fracture seems to have an
effect on the outcome.

Several studies support the adverse effects of antibiotics on bone healing (Table 4).3,49,53,60,69,72, 83,92,118 Cartilage is mainly affected by alteration of the process of endochondral ossification. Quinolones are thought to cause chondrocyte death and degeneration of articular cartilage resulting in fissure formation and cartilage erosions. Their use in children was discouraged by some authors due to their effects on growing cartilage,83 whereas others did not observe any osteoarticular problem or joint deformity.51 Mont et al. suggested that ciprofloxacin decreased cellular proliferation and DNA synthesis, therefore newly differentiated cells are the most affected cell types.83 Ciprofloxacin administration in rats produced diminution of fracture healing during the early stages of repair, decreased chondrocyte number and abnormalities in cartilage morphology.60 Levofloxacin and trovafloxacin had also the same adverse outcome.92
Gentamicin in high concentrations seems to decrease proliferation of osteoblastic progenitors and therefore interfere with the normal healing of bone.61 Prolonged treatment with high doses of tetracycline impairs bone growth and maturation of bone in monkeys.110 In addition, in a rat model of bone repair induced by demineralised bone both gentamycin and tetracycline inhibited new bone formation.69
Other antibiotics such as doxycycline had no effect on bone healing.3 Similarly, cephalothin and tobramycin had no effect on the osteogenic activity of allografts in guinea pigs.95

Table 4 The effect of antibiotics on fracture healing


Model used Drug

1971/Gudmundson 49 Mice


1996/Mont 83

In vitro


2000/Huddleston 60 Rats

2002/Alkan 3






2004/Kim 69


2004/Haleem 53




Doxycycline Doxycycline Levofloxacin and Trovafloxacin
Gentamicin and Tetracycline Gentamicin and Vancomycin Norfloxacin, Ofloxacin, Pefloxacin and Ciproxacin

 No significant effect
 Inhibition of cellular proliferation  No effect on proteoglycans synthesis,
morphology and stain pattern
 Decreased torsional strength and stiffness  Alternations of cartilage morphology
 No effect  Inhibition of matrix metalloproteinases
 Decrease in strength  Inferior quality of callus
 Decreased bone formation  No effect encountered
 Retardation of healing occurred in all fluoroquinolone treated animals
 Differences in terms of healing inhibition were encountered


I. Pountos et al.

Table 5 The effect of anticoagulants on fracture healing


Model used


1955/Stinchfield 113 Rabbits and dogs Heparin and Dicumarol




1997/Muir85 2000/Street 114 2002/Kock 70

Rats Rabbits Rabbits

Heparin and LMWH LMWH Heparin and LMWH

LMWH: low-molecular-weight heparin.

 Delayed healing  Fibrous accumulation in callus
 Decreased rates of bone formation  Increased rates of resorption
 LMWH has milder effect on bone formation  Retardation of bone healing  Heparin impaired the filling of bore holes
whilst LMWH had no effect

It is clear from these studies that quinolones have a detrimental effect on cartilage formation and maintenance. In addition, local application of several antibiotics delivers high concentrations of the drugs which have toxic effect on the growing bone.
The effect of anticoagulant therapy on fracture healing was first studied as early as 1955 by Stinchfield et al.113 The stimulus was a high rate of pseudoarthrosis in patients receiving postoperative anticoagulant therapy for thrombophlebitis. In their study, delayed union was observed in animals receiving anticoagulant therapy. Thereafter several authors studied the effect of anticoagulants on bone healing (Table 5).70,84,85,113,114 Several studies observed that heparin causes decreased trabecular volume through increased resorption and decreased rate of bone formation.84,85,109 This effect was not reversible, as after the end of administration heparin was found sequestered in bone for an extended period of time. Dodds et al. showed a decrease in periosteal activities of glucose 6-phosphate dehydrogenase and of alkaline phosphatase around the fracture in rats, indicating that Vitamin K-antagonists influence the bone metabolism in fresh callus tissue.28 Street et al. showed that the administration of the newer generation anticoagulants, the low-molecular-weight heparins, resulted in the development of less mature bone with reduced torsional strength,114 but this effect was milder compared to that of heparin.85 More recent studies have not been able to reproduce the effect of LMWH on fracture healing.52,70
NSAIDs are frequently used for pain relief due to their pronounced analgesic potency, anti-inflammatory effects and lesser side effects compared with

opioids.10,38,103 They also improve the quality of analgesia and decrease hospital stay.18,119
Prostaglandin E-2 (PGE-2) and Prostaglandin F-2a
(PGF-2a) are both known to stimulate bone formation and increase bone mass.62,79 A fracture leads to high local prostaglandin production and release26
and experimental models showed that local admin-
istration of exogenous prostaglandins can stimulate bone formation.64,66 In rabbits a dose-dependent stimulation of callus formation was observed.66
Our in vitro results suggested that MSCs proliferation
is not affected by the quantity of prostaglandins
present, therefore we speculate that prostaglandins
may have an effect at a later stage of bone healing.96 Furthermore, PGE-2 has been shown to reg-
ulate both BMP-2 and BMP-7 expression suggesting a
potential role in modulation of bone metabolism.5,90
Various publications using several animal
models suggested that NSAIDs, due to their effect
on prostaglandin production, correlated with
various degrees of bone healing impairment (Table 6).2,9,14,23,33,35,40—44,65,71,74,77,93,96,100—102, 104,108,116,126 They produced delayed healing,
decreased mineral content and matrix of the callus and inhibited haversian remodelling.45,100,116 In rat
models treated with NSAIDs, bone density appeared decreased,9 bone stiffness and strength were reduced9,35,36 and histological evidence of
increased fibrous tissue accumulation was apparent.34 Goodman et al. studied the effect of short-
term Cox-2 inhibitor administration after fracture on a rabbit model.44 Their results indicated that if
Cox-2 was administered in the first two weeks after
fracture the bone ingrowth was not affected. In
contrast, if Cox-2 was administered continuously
for six weeks bone ingrowth was substantially
On the other hand, several authors demonstrated
in animal models that NSAIDS have little or no effect on fracture healing.14,40,65,93,100 It should be pointed
out that although their findings provided evidence that ketorolac,100 celecoxib,14 and parecoxib40 do

Pharmacological agents and impairment of fracture healing


Table 6 The effect of NSAIDs on fracture healing

Year/study 1979/Sudmann 116

Model used Drug



1982/Elves 34



1988/Davis 23 1990/Keller65 1993/Adolphson 2 1998/Reikeraas 100

Humans Rabbits Humans Rats

1998/Glassman 43 1999/Sell 108

Humans In vitro

1999/Wurnig 126


2000/Giannoudis 41 Humans

2003/Beck 9


2002/Long 77 2003/Gerstenfeld 40

Rabbits Rats

2003/Giordano 42 2003/Riew104 2004/Brown 14 2004/Goodman 44
2005/Reuben 101

Rats Rabbits Rat Rabbits

2005/Reuben 102 2005/Endo 35 2005/Persson 93

Human Rats Rats

Fluriprophen Indomethacin Piroxicam Ketorolac Trom. and Indomethacin Ketorolac Diclofenac
Ibuprophen and Diclofenac Diclofenac
Celecoxib Ketorolac, Parecoxib
Tenoxicam Indomethacin Celecoxib Rofecoxib
Celecoxib, Rofecoxib and Ketorolac
Celecoxib Etodolac Indomethacin

2006/Pountos 96

In vitro

Diclofenac, Ketorolac, Parecoxib, Ketoprofen, Piroxicam, Meloxicam and Lornoxicam

 Inhibition of haversian remodelling
 No effect on repairing drill holes  Higher effect on older animals  Histological evidence of increased fibrous accumulation
with decrease of osteogenesis and remodelling
 No effect on Colles’ fracture  Effect depends on the extent of trauma  No effect on Colles’ fracture  Ketorolac Tromethamine had no effect on healing
of rat osteotomy whilst indomethacin impaired healing  High rate of non-union in spinal fusion  MSCs proliferation decreased by 18% and osteoblastic
proliferation by 2.5%  No effect on prosthetic loosening after cementless
hip arthroplasty  Increased risk for non-union
 Impaired bone healing, low bending stiffness and bone strength
 No effect on spinal fusion
 Cox-2 selective parecoxib has small effect on delaying fracture healing
 Ketorolac had the highest effect
 Delays in bone healing occurred  Inhibition in early phase of healing  No effect on fracture healing  Less bone ingrowth  Lower effect if given short-term
 Celecoxib, rofecoxib and low dose of ketorolac had no effect on spinal fusion
 High dose of ketorolac increased the rate of non-union
 Short-term administration had no effect on spinal fusion  Bone healing was impaired.  The drug inhibited bone formation in heterotopic
demineralised allogeneic bone matrix but had no effect on autografts
 No effect on MSCs proliferation when cellular medium was supplemented with expected plasma concentrations.
 Negative effect encountered when toxic concentrations used (over 100 mg/ml).
 NSAIDs in plasma concentrations had no effect on osteogenesis

2006/Krischak 71


2006/Leonelli 74


Diclofenac Rofecoxib and Ibuprophen

 Impairment of callus maturation  Non-union in 65% of rofecoxib treated and 17.6% of
ibuprophen treated rats

not affect fracture healing, they failed to demon-
strate similar effects after administration of indomethacin.14,100 Indomethacin in a rat model was also
found to have no effect on bone formation on auto-

grafts but to affect bone formation in demineralised allogeneic bone matrix.93 In addition, indomethacin
was found not to influence bone growth in small
defects but its effect was proportional to the extent

of traumatised bone.55 Spinal fusion in rabbits was not inhibited by celecoxib.77
In humans very few data exist demonstrating a potential relationship between bone healing and NSAIDs. Davis and Ackroyd studied the effect of two weeks administration of flurbiprophen on Colles’ fractures.23 No impairment on fracture healing union was encountered. Giannoudis et al. showed a strong association between long-term NSAIDs administration and non-union development.41 In patients undergoing spinal fusion the short-term administration of either low dose of ketorolac, celecoxib and rofecoxib had no effect on the rate of non-union.101,102 High or long-term postoperative doses of NSAIDS had an increased risk of developing non-union.25,43,101 In addition, the relation between administration of NSAIDs and both osteopenia after Colles’ fracture and aseptic loosening after hip replacement was studied,.2,126 and no correlation was seen. A significant effect was found by Burd et al. in a retrospective study on patients receiving indomethacin for prevention of heterotopic bone formation in acetabular fractures.16 Patients who did not receive indomethacin had significantly fewer non-unions of associated long bone fractures than patients who received it.16
Heterotopic bone formation (HBF) after major hip surgery seems to be connected with male gender,105 operative techniques29 and idiopathic hyperostosis of the skeleton.12 NSAIDs appear to prevent this process.87 Neal et al. in a systematic survey of 13 trials reported an overall decrease of HBF of 57%.87 The duration of NSAIDs administration seems unrelated to the development of HBF. Pritchett and Gebuhr et al. administered NSAIDs for two and five days postoperatively.39,97 They reported a reduction of HBF of 48— 50%. In contrast, great variability existed in similar studies with administration of NSAIDs varying from 10 to 92 days and HBF reduction from 7 to 97%.16,17,82,121
NSAIDs have a clear benefit in everyday clinical practice, and the contradictory results from these various animal models, as well the absence of well randomised clinical data, suggest that more research should be conducted on this topic; the animal studies may not reflect the clinical setting. In addition, the exact biology of heterotopic bone formation, where NSAIDs play a preventive role, remains unclear and cannot be considered as a reflection of bone healing. We believe that clinicians should weigh up their potential risks and benefits.38

I. Pountos et al.
nates might be candidates to up-modulate bone healing.4,46 Increased mineral content, volume and strength of callus were observed in animal models after bisphosphonate administration.4,46,80,94 Although these observations have been confirmed by several studies, concern exists as some authors suggest that the arrest of bone remodelling may produce osteoporotic, weak bone.76,81 Still, the available data on the use of bisphosphonates underline their importance in the prevention of additional fractures in osteoporotic patients, who are often diagnosed after a fracture has occurred. The possible negative effects on bone remodelling do not seem to outweigh their beneficial effects at this point.
Intensive research is currently focused on the treatment of fractures by the application of cells, scaffolds, growth factors or by development and design of new implants. Today’s knowledge on the effect of several drugs on bone healing is characterised by inconclusive and controversial results from several animal models, together with absence of univocal clinical data. It is clear, however, that some pharmacological agents impair the bone healing process, and small changes in medication of patients can contribute to a better outcome. This should be borne in mind by all physicians involved in the treatment of bone disorders, whether dealing with fractures or degenerative diseases. Further research in the foreseeable future may allow clinicians to understand better the inhibitory effect of several pharmacological agents on the fracture healing process and the mechanisms governing bone repair and regeneration.
No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article. No funds were received in support of this study.
Conflicts of interest
There are no conflicts of interest.

Bisphosphonates are widely used bone anabolic agents inhibiting bone resorption. Based on this principle, several authors suggested that bisphospho-

1. Abu EO, Horner A, Kusec V, et al. The localization of the functional glucocorticoid receptor alpha in human bone. J Clin Endocrinol Metab 2000;85:883—9.

Pharmacological agents and impairment of fracture healing


2. Adolphson P, Abbaszadegan H, Jonsson U, et al. No effects of piroxicam on osteopenia and recovery after Colles’ fracture. A randomized, double-blind, placebo-controlled, prospective trial. Arch Orthop Trauma Surg 1993;112: 127—30.
3. Alkan A, Erdem E, Gunhan O, Karasu C. Histomorphometric evaluation of the effect of doxycycline on the healing of bone defects in experimental diabetes mellitus: a pilot study. J Oral Maxillofac Surg 2002;60:898—904.
4. Amanat N, Brown R, Bilston LE, Little DG. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res 2005;235:1029—34.
5. Arikawa T, Omura K, Morita I. Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells. J Cell Physiol 2004;200:400—6.
6. Aslan M, Simsek G, Yildirim U. Effects of short-term treatment with systemic prednisone on bone healing: an experimental study in rats. Dent Traumatol 2005;21:222—5.
7. Augat P, Margevicius K, Simon J, et al. Local tissue properties in bone healing: influence of size and stability of the osteotomy gap. J Orthop Res 1998;16:475—81.
8. Augat P, Merk J, Ignatius A, et al. Early, full weightbearing with flexible fixation delays fracture healing. Clin Orthop Relat Res 1996;328:194—202.
9. Beck A, Krischak G, Sorg T, et al. Influence of diclofenac (group of nonsteroidal anti-inflammatory drugs) on fracture healing. Arch Orthop Trauma Surg 2003;123:327—32.
10. Beck A, Salem K, Krischak G, et al. Nonsteroidal antiinflammatory drugs (NSAIDs) in the perioperative phase in traumatology and orthopedics effects on bone healing. Oper Orthop Traumatol 2005;17:569—78.
11. Beljan JR. Osseous malrepair in calcium-deficient states. Life Sci Space Res 1974;12:133—9.
12. Blasingame JP, Resnick D, Coutts RD, Danzig LA. Extensive spinal osteophytosis as a risk factor for heterotopic bone formation after total hip arthroplasty. Clin Orthop Relat Res 1981;161:191—7.
13. Blunt JW, Plotz CM, Lattes R, et al. Effect of cortisone on experimental fractures in the rabbit. Proc Soc Exp Biol Med 1950;73:678—81.
14. Brown KM, Saunders MM, Kirsch T, et al. Effect of COX-2specific inhibition on fracture-healing in the rat femur. J Bone Joint Surg Am 2004;86-A:116—23.
15. Burchardt H, Glowczewskie Jr FP, Enneking WF. The effect of adriamycin and methotrexate on the repair of segmental cortical autografts in dogs. J Bone Joint Surg Am 1983;65:103—8.
16. Burd TA, Hughes MS, Anglen JO. Heterotopic ossification prophylaxis with indomethacin increases the risk of longbone nonunion. J Bone Joint Surg Br 2003;85(5):700—5.
17. Burssens A, Thiery J, Kohl P, et al. Prevention of heterotopic ossification with tenoxicam following total hip arthroplasty: a double-blind, placebo-controlled dose-finding study. Acta Orthop Belg 1995;61:205—11.
18. Camu F, Beecher T, Recker DP, Verburg KM. Valdecoxib, a COX-2-specific inhibitor, is an efficacious, opioid-sparing analgesic in patients undergoing hip arthroplasty. Am J Ther 2002;9:43—51.
19. Castella FB, Garcia FB, Berry EM, et al. Nonunion of the humeral shaft: long lateral butterfly fracture–—a nonunion predictive pattern? Clin Orthop Relat Res 2004;424: 227—30.
20. Chahal J, Stephen DJ, Bulmer B, et al. Factors associated with outcome after subtalar arthrodesis. J Orthop Trauma 2006;20:555—61.

21. Claes LE, Wilke HJ, Augat P, et al. Effect of dynamization on gap healing of diaphyseal fractures under external fixation. Clin Biomech (Bristol Avon) 1995;10:227—34.
22. Cruess RL, Dumont J. Fracture healing. Can J Surg 1975;18:403—13.
23. Davis TR, Ackroyd CE. Non-steroidal anti-inflammatory agents in the management of Colles’ fractures. Br J Clin Pract 1988;42:184—9.
24. Day SM, DeHeer DH. Reversal of the detrimental effects of chronic protein malnutrition on long bone fracture healing. J Orthop Trauma 2001;15:47—53.
25. Deguchi M, Rapoff AJ, Zdeblick TA. Posterolateral fusion for isthmic spondylolisthesis in adults: analysis of fusion rate and clinical results. J Spinal Disord 1998;11:459—64.
26. Dekel S, Lenthall G, Francis MJ. Release of prostaglandins from bone and muscle after tibial fracture. An experimental study in rabbits. J Bone Joint Surg Br 1981;63B:185—9.
27. Dimitriou R, Tsiridis E, Giannoudis PV. Current concepts of molecular aspects of bone healing. Injury 2005;36: 1392—404.
28. Dodds RA, Catterall A, Bitensky L, Chayen J. Effects on fracture healing of an antagonist of the vitamin K cycle. Calcif Tissue Int 1984;36(2):233—8.
29. Duck HJ, Mylod Jr AG. Heterotopic bone in hip arthroplasties. Cemented versus noncemented. Clin Orthop Relat Res 1992;282:145—53.
30. Duthie RB, Barker AN. The histochemistry of the preosseous stage of bone repair studied by autoradiography; the effect of cortisone. J Bone Joint Surg Br 1955;37-B:691—700.
31. Ehrilch P, Harold T, Hunt TK. Effects of vitamin A and glucocorticoids upon inflammation and collagen synthesis. Ann Surg 1973;177:222—7.
32. Ehrlich P, Hunt T. Effects of cortisone & vit A on wound healing. Ann Surg 1968;167:324—8.
33. Einhorn TA. The cell and molecular biology of fracture healing. Clin Orthop Relat Res 1998;355:S7—21.
34. Elves MW, Bayley I, Roylance PJ. The effect of indomethacin upon experimental fractures in the rat. Acta Orthop Scand 1982;53:35—41.
35. Endo K, Sairyo K, Komatsubara S, et al. Cyclooxygenase-2 inhibitor delays fracture healing in rats. Acta Orthop 2005;76:470—4.
36. Endo K, Sairyo K, Komatsubara S, et al. Cyclooxygenase-2 inhibitor inhibits the fracture healing. J Physiol Anthropol Appl Hum Sci 2002;21:235—8.
37. Friedlaender GE, Tross RB, Doganis AC, et al. Effects of chemotherapeutic agents on bone. I. Short-term methotrexate and doxorubicin (adriamycin) treatment in a rat model. J Bone Joint Surg Am 1984;66:602—7.
38. Gajraj NM. The effect of cyclooxygenase-2 inhibitors on bone healing. Reg Anesth Pain Med 2003;28:456—65.
39. Gebuhr P, Sletgard J, Dalsgard J, et al. Heterotopic ossification after hip arthroplasty: a randomized double-blind multicenter study tenoxicam in 147 hips. Acta Orthop Scand 1996;67:29—32.
40. Gerstenfeld LC, Thiede M, Seibert K, et al. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs. J Orthop Res 2003;21:670—5.
41. Giannoudis PV, MacDonald DA, Matthews SJ, et al. Nonunion of the femoral diaphysis. The influence of reaming and nonsteroidal anti-inflammatory drugs. J Bone Joint Surg Br 2000;82:655—8.
42. Giordano V, Giordano M, Knackfuss IG, et al. Effect of tenoxicam on fracture healing in rat tibiae. Injury 2003;34:85—94.

43. Glassman SD, Rose SM, Dimar JR, et al. Puno RM. The effect of postoperative nonsteroidal anti-inflammatory drug administration on spinal fusion. Spine 1998;23:834—8.
44. Goodman SB, Ma T, Mitsunaga L, et al. Temporal effects of a COX-2-selective NSAID on bone ingrowth. J Biomed Mater Res A 2005;72:279—87.
45. Goodman S, Ma T, Trindade M, et al. COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 2002;20:1164—9.
46. Goodship AE, Walker PC, McNally D, et al. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol 1994;5:S53—5.
47. Gravel CA, Le TT, Chapman MW. Effect of neoadjuvant chemotherapy on distraction osteogenesis in the goat model. Clin Orthop Relat Res 2003;412:213—24.
48. Guarniero R, de Barros Filho TE, Tannuri U, et al. Study of fracture healing in protein malnutrition. Rev Paul Med 1992;110:63—8.
49. Gudmundson C. Oxytetracycline-induced disturbance of fracture healing. J Trauma 1971;11:511—7.
50. Gullihorn L, Karpman R, Lippiello L. Differential effects of nicotine and smoke condensate on bone cell metabolic activity. J Orthop Trauma 2005;19:17—22.
51. Gurpinar AN, Balkan E, Kilic N, et al. The effects of a fluoroquinolone on the growth and development of infants. Int Med Res 1997;25:302—6.
52. Hak DJ, Stewart RL, Hazelwood SJ. Effect of low molecular weight heparin on fracture healing in a stabilized rat femur fracture model. J Orthop Res 2006;24(4):645—52.
53. Haleem AA, Rouse MS, Lewallen DG, et al. Gentamicin and vancomycin do not impair experimental fracture healing. Clin Orthop Relat Res 2004;427:22—4.
54. Hausman MR, Schaffler MB, Majeska RJ. Prevention of fracture healing in rats by an inhibitor of angiogenesis. Bone 2001;29:560—4.
55. Hazan EJ, Hornicek FJ, Tomford W, et al. The effect of adjuvant chemotherapy on osteoarticular allografts. Clin Orthop Relat Res 2001;385:176—81.
56. Hellewell AB, Beljan JR, Goldman M. Effect of chronic administration of glucocorticoid (prednisolone) on the rate of healing of experimental osseous defects. Clin Orthop Relat Res 1974;100:349—55.
57. Hilibrand AS, Fye MA, Emery SE, et al. Impact of smoking on the outcome of anterior cervical arthrodesis with interbody or strut-grafting. J Bone Joint Surg Am 2001;83A:668—73.
58. Hogevold HE, Grogaard B, Reikeras O. Effects of short-term treatment with corticosteroids and indomethacin on bone healing. A mechanical study of osteotomies in rats. Acta Orthop Scand 1992;63:607—11.
59. Hornicek FJ, Gebhardt MC, Tomford WW, et al. Factors affecting nonunion of the allograft-host junction. Clin Orthop Relat Res 2001;382:87—98.
60. Huddleston PM, Steckelberg JM, Hanssen AD, et al. Ciprofloxacin inhibition of experimental fracture healing. J Bone Joint Surg Am 2000;82:161—73.
61. Isefuku S, Joyner CJ, Simpson AH. Gentamicin may have an adverse effect on osteogenesis. J Orthop Trauma 2003;17:212—6.
62. Jee WS, Ma YF. The in vitro anabolic actions of prostaglandins in bone. Bone 1997;21:297—304.
63. Jee WS, Park HZ, Roberts WE, Kenner GH. Corticosteroid and bone. Am J Anat 1970;129:477—9.
64. Ke HZ, Jee WS, Mori S, et al. Effects of long-term daily administration of prostaglandin-E2 on maintaining elevated proximal tibial metaphyseal cancellous bone mass in male rats. Calcif Tissue Int 1992;50:245—52.

I. Pountos et al.
65. Keller J, Kjaersgaard-Andersen P, Bayer-Kristensen I, Melsen F. Indomethacin and bone trauma. Effects on remodelling of rabbit bone. Acta Orthop Scand 1990;61:66—9.
66. Keller J, Klamer A, Bak B, Suder P. Effect of local prostaglandin E2 on fracture callus in rabbits. Acta Orthop Scand 1993;64:59—63.
67. Key JA, Odell RT, Taylor LW. Failure of cortisone to delay or to prevent the healing of fractures in rats. J Bone Joint Surg Am 1952;24:665—75.
68. Khoo DB. The effect of chemotherapy on soft tissue and bone healing in the rabbit model. Ann Acad Med Singapore 1992;21:217—21.
69. Kim SG, Chung TY, Kim MS, Lim SC. The effect of high local concentrations of antibiotics on demineralized bone induction in rats. J Oral Maxillofac Surg 2004;62:708—13.
70. Kock HJ, Werther S, Uhlenkott H, Taeger G. Influence of unfractionated and low-molecular-weight heparin on bone healing: an animal model. Unfallchirurg 2002;105: 791—6.
71. Krischak GD, Augat P, Sorg T, et al. Effects of diclofenac on periosteal callus maturation in osteotomy healing in an animal model. Arch Orthop Trauma Surg 2007;127:3—9.
72. Lamparter S, Slight SH, Weber KT. Doxycycline and tissue repair in rats. J Lab Clin Med 2002;139:295—302.
73. Lee OK, Coathup MJ, Goodship AE, Blunn GW. Use of mesenchymal stem cells to facilitate bone regeneration in normal and chemotherapy-treated rats. Tissue Eng 2005;11:1727—35.
74. Leonelli SM, Goldberg BA, Safanda J, et al. Effects of a cyclooxygenase-2 inhibitor (rofecoxib) on bone healing. Am J Orthop 2006;35:79—84.
75. Li J, Law HK, Lau YL, Chan GC. Differential damage and recovery of human mesenchymal stem cells after exposure to chemotherapeutic agents. Br J Haematol 2004;127: 326—34.
76. Li J, Mori S, Kaji Y, et al. Effect of bisphosphonate (incadronate) on fracture healing of long bones in rats. J Bone Miner Res 1999;14:969—79.
77. Long J, Lewis S, Kuklo T, et al. The effect of cyclooxygenase2 inhibitors on spinal fusion. J Bone Joint Surg Am 2002;84:1763—8.
78. Luppen CA, Blake CA, Ammirati KM, et al. Recombinant human bone morphogenetic protein-2 enhances osteotomy healing in glucocorticoid-treated rabbits. J Bone Miner Res 2002;17:301—10.
79. Ma YF, Li XJ, Jee WS, et al. Effects of prostaglandin E2 and F2 alpha on the skeleton of osteopenic ovariectomized rats. Bone 1995;17:549—54.
80. Madsen JE, Berg-Larsen T, Kirkeby OJ, et al. No adverse effects of clodronate on fracture healing in rats. Acta Orthop Scand 1998;69:532—6.
81. Mashiba T, Hirano T, Turner CH, et al. Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib. J Bone Miner Res 2000;15:613—20.
82. Matta J, Siebenrock K. Does indomethacin reduce heterotopic bone formation after operation for acetabular fractures–—a prospective randomized study? J Bone Joint Surg (Br) 1997;79:959—63.
83. Mont MA, Mathur SK, Frondoza CG, Hungerford DS. The effects of ciprofloxacin on human chondrocytes in cell culture. Infection 1996;24:151—5.
84. Muir JM, Andrew M, Hirsh J, et al. Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood 1996;88:1314—20.
85. Muir JM, Hirsh J, Weitz JI, et al. A histomorphometric comparison of the effects of heparin and low-molecular-

Pharmacological agents and impairment of fracture healing


weight heparin on cancellous bone in rats. Blood 1997;89: 3236—42. 86. Murakami H, Kowalewski K. Effects of cortisone and an anabolic androgen on the fractured humerus in guinea pigs: clinical and histological study over a six-week period of fracture healing. Can J Surg 1966;9:425—34. 87. Neal BC, Rodgers A, Clark T, et al. A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 2000;71: 122—8. 88. Nilsson OS, Bauer FC, Brostrom LA, Nilsonne U. Effect of the antineoplastic agent methotrexate on experimental heterotopic new bone formation in rats. Cancer Res 1984;44: 1653—6. 89. O’Brien CA, Jia D, Plotkin LI, et al. Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 2004;145(4):1835—41. 90. Paralkar VM, Grasser WA, Mansolf AL, et al. Regulation of BMP-7 expression by retinoic acid and prostaglandin E(2). J Cell Physiol 2002;190:207—17. 91. Parker MJ, Raghavan R, Gurusamy K. Incidence of fracturehealing complications after femoral neck fractures. Clin Orthop Relat Res 2007;458:175—9. 92. Perry AC, Prpa B, Rouse MS, et al. Levofloxacin and trovafloxacin inhibition of experimental fracture-healing. Clin Orthop Relat Res 2003;14:95—100. 93. Persson PE, Sisask G, Nilsson O. Indomethacin inhibits bone formation in inductive allografts but not in autografts: studies in rat. Acta Orthop 2005;76:465—9. 94. Peter CP, Cook WO, Nunamaker DM, et al. Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res 1996;14:74—9. 95. Petri WH. Osteogenic activity of antibiotic-supplemented bone allografts in the guinea pig. J Oral Maxillofac Surg 1984;42:631—6. 96. Pountos I, Georgouli T, Jones E, et al. The effect of NSAIDs on the proliferation of mesenchymal stem cells and bone healing. Injury 2006;37:3. 97. Pritchett JW. Ketorolac prophylaxis against heterotopic ossification after hip replacement. Clin Orthop Relat Res 1995;314:162—5. 98. Puzas JE, O’Keefe RJ, Schwarz EM, Zhang X. Pharmacologic modulators of fracture healing: the role of cyclooxygenase inhibition. J Musculoskelet Neuronal Interact 2003;3: 308—12. 99. Radi ZA, Khan NK. Effects of cyclooxygenase inhibition on bone, tendon, and ligament healing. Inflamm Res 2005;54: 358—66. 100. Reikeraas O, Engebretsen L. Effects of ketoralac tromethamine and indomethacin on primary and secondary bone healing. An experimental study in rats. Arch Orthop Trauma Surg 1998;118:50—2. 101. Reuben SS, Ablett D, Kaye R. High dose nonsteroidal antiinflammatory drugs compromise spinal fusion. Can J Anaesth 2005;52:506—12. 102. Reuben SS, Ekman EF. The effect of cyclooxygenase-2 inhibition on analgesia and spinal fusion. J Bone Joint Surg Am 2005;87:536—42. 103. Reuben SS, Fingeroth R, Krushell R, Maciolek H. Evaluation of the safety and efficacy of the perioperative administration of rofecoxib for total knee arthroplasty. J Arthroplasty 2002;17:26—31. 104. Riew KD, Long J, Rhee J, et al. Time-dependent inhibitory effects of indomethacin on spinal fusion. J Bone Joint Surg Am 2003;85:632—4.

105. Ritter MA, Vaughan RB. Ectopic ossification after total hip arthroplasty. Predisposing factors, frequency, and effect on results. J Bone Joint Surg Am 1977;59:345—51.
106. Sato S, Kim T, Arai T, et al. Comparison between the effects of dexamethasone and indomethacin on bone wound healing. Jpn J Pharmacol 1986;42:71—8.
107. Sawin PD, Dickman CA, Crawford NR, et al. The effects of dexamethasone on bone fusion in an experimental model of posterolateral lumbar spinal arthrodesis. J Neurosurg 2001;94:76—81.
108. Sell S, Teschner M, Gaissmaier C, et al. Effect of diclofenac on human osteoblasts and their stromal precursors in vitro in relation to arthroplasty. Z Rheumatol 1999;58: 13—20.
109. Shaughnessy SG, Hirsh J, Bhandari M, et al. A histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in rats. Blood 1999;93:1231—6.
110. Simmons DJ, Chang SL, Russell JE, et al. The effect of protracted tetracycline treatment on bone growth and maturation. Clin Orthop Relat Res 1983;180: 253—9.
111. Sisson HA, Hadfield GJ. The influence of cortisone on the repair of experimental fracture in rabbit. Br J Surg 1951;38:172—8.
112. Sommer-Tsilenis E, Sauer HD, Kruse HP. Delaying effect of cyclophosphamide on bone fracture healing chemical analyses of rat femora. Arch Orthop Trauma Surg 1983;101:89—93.
113. Stinchfield FE, Sankaran B, Samilson R. The effect of anticoagulant therapy on bone repair. J Bone Joint Surg Am 1956;38:270—82.
114. Street JT, McGrath M, O’Regan K, et al. Thromboprophylaxis using a low molecular weight heparin delays fracture repair. Clin Orthop Relat Res 2000;381:278—89.
115. Subasi M, Kapukaya A, Kesemenli C, et al. Effect of chemotherapeutic agents on distraction osteogenesis. An experimental investigation in rabbits. Arch Orthop Trauma Surg 2001;121:417—21.
116. Sudmann E, Bang G. Indomethacin-induced inhibition of haversian remodelling in rabbits. Acta Orthop Scand 1979;50:621—7.
117. Tortolani PJ, Park AE, Louis-Ugbo J, et al. The effects of doxorubicin (adriamycin) on spinal fusion: an experimental model of posterolateral lumbar spinal arthrodesis. Spine J 2004;4:669—74.
118. Tuncay I, Ozbek H, Kosem M, Unal O. A comparison of effects of fluoroquinolones on fracture healing (an experimental study in rats). Ulus Travma Acil Cerrahi Derg 2005;11:17—22.
119. Turner DM, Warson JS, Wirt TC, et al. The use of ketorolac in lumbar spine surgery: a cost-benefit analysis. J Spinal Disord 1995;8:206—12.
120. Vigorita JV. Orthopaedic pathology. 1st ed. Lippincott & Wilkins. p. 85—97.
121. Wahlstrom O, Risto O, Djerf K, Hammerby S. Heterotopic bone formation prevented by diclofenac. Prospective study of 100 hip arthroplasties. Acta Orthop Scand 1991;62: 419—21.
122. Waters RV, Gamradt SC, Asnis P, et al. Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model. Acta Orthop Scand 2000;71:316—21.
123. Weinstein RS, Jilka RL, Parfitt AM, Manolagas SC. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 1998;102(July (2)):274—82.

Preparing to load PDF file. please wait...

0 of 0
Pharmacological agents and impairment of fracture healing